1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The Threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. MEXICO DRUG DELIVERY MARKET, BY TYPE
5.1. Introduction
5.2. Topical
5.3. Injectable
5.4. Oral
5.5. Ocular
5.6. Nasal
5.7. Pulmonary
5.8. Others
6. MEXICO DRUG DELIVERY MARKET, BY APPLICATION
6.1. Introduction
6.2. Cancer
6.3. Cardiovascular
6.4. Diabetes
6.5. Autoimmune Diseases
6.6. Respiratory Diseases
6.7. Others
7. MEXICO DRUG DELIVERY MARKET, BY END-USERS
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centres
7.4. Homecare settings
7.5. Diagnostic Centers
7.6. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrative
8.3. Mergers, Acquisition, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Pfizer
9.2. GlaxoSmithKline
9.3. Roche
9.4. Bayer
9.5. Bristol-Myers Squibb
9.6. Genomma Labs
9.7. Laboratorios Liomont
9.8. Perrigo
9.9. Sanofi
9.10. PiSA® Farmacéutica